SAC Capital Lowers Stake in Amylin Pharmaceuticals, Inc. (AMLN) to 4.34%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

July 18, 2011 4:09 PM EDT
In a 13G filing on Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN), hedge fund SAC Capital disclosed a 4.34%, or 6,327,861 share, stake in the company. This is down 10.74% from the 7,089,049 shares previously held.

For more notable holders of Amylin Pharmaceuticals, Inc. stock click here. For more information on SAC Capital click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

13Gs, Hedge Funds

Related Entities

SAC Capital, Steven A. Cohen, Hedge Funds, 13G